<DOC>
	<DOCNO>NCT01823042</DOCNO>
	<brief_summary>Crohn 's disease ( CD ) agnogenic disease lifelong relapse tendency even surgery treatment.So maintain remission medication routinely give patient surgery.But maintain remission medication , azathioprine,6-MP , ciclosporin , tripterygium glycoside , onset time.The therapeutic effect may appear 3 months~6months take medicine.There treatment blank period surgery onset time maintain remission medications.Enteral nutrition use induction remission maintain remission CD.May fill treatment blank period .</brief_summary>
	<brief_title>The Efficacy Enteral Nutrition Fill Treatment Blank Period Postoperative Maintain Remission Medication Crohn 's Disease ( CD )</brief_title>
	<detailed_description>Crohn 's disease ( CD ) agnogenic disease lifelong relapse tendency even surgery treatment.So maintain remission medication routinely give patient surgery.But maintain remission medication , azathioprine,6-MP , ciclosporin , tripterygium glycoside , onset time.The therapeutic effect may appear 3 months~6months take medicine.There treatment blank period surgery onset time maintain remission medications.Enteral nutrition use induction remission maintain remission CD.May fill treatment blank period .</detailed_description>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Azathioprine</mesh_term>
	<mesh_term>Benzocaine</mesh_term>
	<criteria>Subjects definitive diagnosis Crohn 's disease , base WHO criteria Subjects curative resection/ileocolonic anastomosis，pathologically diagnose Crohn 's disease Lesions locate ileum ileocecal region Males females ≥ 18 year old , include woman pregnant lactating time enrollment . Body weight 40 100 kg , inclusive . Subjects CDAI score &lt; 150 week 0 Able swallow tablet Are capable provide write informed consent obtain time enrollment Willing adhere study visit schedule protocol requirement . Bacterial , viral microbial infection ( include HIV ) follow medication take within 12 week surgery : cyclosporine , tacrolimus , sirolimus , mycophenolate mofetil , investigational drug ongoing therapy Crohn 's disease : 5ASA compound , steroid , immune modifier , systemic antibiotic , tube feed Needing orally administer corticosteroid treatment disease . Inhaled dermatologic preparation acceptable . Previous current use infliximab . current use prescription dos chronic/frequent use NSAIDs Treatment narcotic pain medication . ( Antidiarrheal agent loperamide diphenoxylate permit , provide dose increase study period . ) History pancreatitis , except subject know remove cause ( gallstone pancreatitis ) WBC &lt; 3.0 x 109/L , hemoglobin &lt; 80 g/L , Platelets &lt; 50,000/mm3 time enrollment ( within previous 6 month , know ) History abnormal liver function test , include AST ALT &gt; 1.5 time upper limit normal , alkaline phosphatase &gt; 2 time upper limit normal , total bilirubin &gt; 2.5 mg/dL screening ( within previous 6 month , know ) With short bowel syndrome ( define require oral parenteral supplemental total nutrition maintain stable body weight , 100 cm small bowel resect ) History malignancy Women pregnant lactating time enrollment , intend study period . Participation clinical trial within past 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Crohn 's Disease</keyword>
	<keyword>maintain remission</keyword>
	<keyword>postoperative recurrence</keyword>
	<keyword>surgery</keyword>
	<keyword>living quality</keyword>
</DOC>